Methods: We retrospectively reviewed the records of 151 infantile severe hemangioma patients who were treated with oral propranolol in Childrens Hospital 1 from June 2010 to January 2020, collected information on sociodemographic data, treatment indications, IH involution, IH relapse, and treatment side effects.